InsidersTradesSigma
Follow the 명문제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 명문제약 has recorded 3 public disclosures. Market capitalisation: €36.6bn. The latest transaction was reported on 2 July 2026 (Other). Among the most active insiders: 임기섭. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Myungmoon Pharmaceutical 是一家韩国制药公司，专注于药物的开发和营销。该公司在 XKRX 市场上市。